Functional Roles of NKp46 in Transplantation

NKp46 在移植中的功能作用

基本信息

  • 批准号:
    8717580
  • 负责人:
  • 金额:
    $ 19.69万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-09 至 2016-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Natural killer (NK) cells are effector cells of the innate immune system that can lyse target cells without prior sensitization, and have an important role in host defense to pathogens and transformed cells. NK cell function is controlled by a balance of negative and positive signals transmitted via germ-line encoded inhibitory and activating receptors. Although the concept of "missing-self" would suggest NK cells could target foreign allografts, the prevailing dogma has been that NK cells are not active participants in the mechanisms that culminate in graft rejection. Recent studies, however, challenge this conclusion and instead implicate NK cells in both acute and chronic allograft rejection. Quite paradoxically, NK cells have also been shown to facilitate tolerance to an allograft. To reconcile these disparate observations we hypothesized that NK cells, through expression and function of activating receptors, regulate other cells of the immune system especially dendritic cells (DC). Indeed we have demonstrated that DC- mediated activation of NK cells is dependent upon signaling through the NKp46 activation receptor. The goal of this exploratory/developmental proposal is to determine how NK interactions regulate the adaptive immune response after transplantation. We propose two integrated Specific Aims: 1) determine the phenotypic and functional features of NK cells after transplantation and 2) determine how NKp46 contributes to the function of NK cells post-transplant, to test our hypothesis that NKp46 is important in regulating NK-mediated immune functions post-transplant. Our innovative study will have important implications in designing strategies to prevent graft rejection and promote tolerance to an allograft.
描述(由申请人提供):自然杀伤(NK)细胞是先天免疫系统的效应细胞,可在不事先致敏的情况下裂解靶细胞,并在宿主防御病原体和转化细胞中发挥重要作用。NK细胞功能由通过生殖系编码的抑制性和激活性受体传递的负信号和正信号的平衡控制。虽然“缺失自我”的概念表明NK细胞可以靶向异体移植物,但普遍的教条是NK细胞不是导致移植物排斥的机制的积极参与者。然而,最近的研究挑战了这一结论,而是将NK细胞与急性和慢性同种异体移植排斥反应联系起来。相当矛盾的是,NK细胞也被证明有助于对同种异体移植物的耐受。为了调和这些不同的观察结果,我们假设NK细胞通过活化受体的表达和功能调节免疫系统的其他细胞,特别是树突状细胞(DC)。事实上,我们已经证明,DC介导的NK细胞活化依赖于通过NKp 46活化受体的信号传导。这一探索性/发展性建议的目标是确定NK相互作用如何调节移植后的适应性免疫应答。我们提出了两个综合的具体目标:1)确定移植后NK细胞的表型和功能特征,2)确定NKp 46如何促进移植后NK细胞的功能,以验证我们的假设,即NKp 46在调节移植后NK介导的免疫功能中很重要。我们的创新性研究将对设计预防移植排斥反应和促进同种异体移植耐受的策略具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sheri M. Krams其他文献

Graft-derived extracellular vesicles transport miRNAs to modulate macrophage polarization after heart transplantation
移植心脏来源的细胞外囊泡运输微小RNA以调节心脏移植后的巨噬细胞极化
  • DOI:
    10.1016/j.ajt.2024.11.021
  • 发表时间:
    2025-04-01
  • 期刊:
  • 影响因子:
    8.200
  • 作者:
    Lei Zheng;Shuling Han;Jeanna Enriquez;Olivia M. Martinez;Sheri M. Krams
  • 通讯作者:
    Sheri M. Krams
Mutations in latent membrane protein 1 of Epstein-Barr virus are associated with increased risk of posttransplant lymphoproliferative disorder in children
爱泼斯坦-巴尔病毒潜伏膜蛋白 1 的突变与儿童移植后淋巴增殖性疾病风险增加有关
  • DOI:
    10.1016/j.ajt.2023.02.014
  • 发表时间:
    2023-05-01
  • 期刊:
  • 影响因子:
    8.200
  • 作者:
    Olivia M. Martinez;Sheri M. Krams;Mark A. Robien;Mary G. Lapasaran;Matthew P. Arvedson;Andrea Reitsma;Yarl Balachandran;Aleishia Harris-Arnold;Kenneth Weinberg;Scott D. Boyd;Brian Armstrong;Amber Trickey;Clare J. Twist;Dita Gratzinger;Brent Tan;Merideth Brown;Clifford Chin;Dev M. Desai;Thomas M. Fishbein;George V. Mazariegos;Carlos O. Esquivel
  • 通讯作者:
    Carlos O. Esquivel

Sheri M. Krams的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sheri M. Krams', 18)}}的其他基金

Epstein Barr Virus Driven Mechanisms of Post Transplant Lymphoproliferative Disease
EB 病毒驱动的移植后淋巴增殖性疾病的机制
  • 批准号:
    10755055
  • 财政年份:
    2023
  • 资助金额:
    $ 19.69万
  • 项目类别:
Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients
外泌体和儿科移植受者同种异体移植结果中的免疫反应
  • 批准号:
    10612125
  • 财政年份:
    2022
  • 资助金额:
    $ 19.69万
  • 项目类别:
Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients
外泌体和儿科移植受者同种异体移植结果中的免疫反应
  • 批准号:
    10339207
  • 财政年份:
    2021
  • 资助金额:
    $ 19.69万
  • 项目类别:
Exosomes and the Immune Response in Allograft Outcomes in Pediatric Transplant Recipients
外泌体和儿科移植受者同种异体移植结果中的免疫反应
  • 批准号:
    10188897
  • 财政年份:
    2020
  • 资助金额:
    $ 19.69万
  • 项目类别:
Plasmacytoid Dendritic Cell microRNAS in Transplantation
浆细胞样树突状细胞 microRNAS 在移植中的应用
  • 批准号:
    9302655
  • 财政年份:
    2016
  • 资助金额:
    $ 19.69万
  • 项目类别:
Functional Roles of NKp46 in Transplantation
NKp46 在移植中的功能作用
  • 批准号:
    8460369
  • 财政年份:
    2013
  • 资助金额:
    $ 19.69万
  • 项目类别:
Tolerance Induction and Viral Infection in Liver Transplantation
肝移植中的耐受诱导和病毒感染
  • 批准号:
    8084888
  • 财政年份:
    2010
  • 资助金额:
    $ 19.69万
  • 项目类别:
NK Cell Interactions in Transplantation
移植中 NK 细胞的相互作用
  • 批准号:
    7872165
  • 财政年份:
    2009
  • 资助金额:
    $ 19.69万
  • 项目类别:
IMMUNE-MEDIATED BILE DUCT INJURY IN BILIARY ATRESIA
胆道闭锁中免疫介导的胆管损伤
  • 批准号:
    6091826
  • 财政年份:
    2000
  • 资助金额:
    $ 19.69万
  • 项目类别:
IMMUNE-MEDIATED BILE DUCT INJURY IN BILIARY ATRESIA
胆道闭锁中免疫介导的胆管损伤
  • 批准号:
    6381830
  • 财政年份:
    2000
  • 资助金额:
    $ 19.69万
  • 项目类别:

相似海外基金

Operational tolerance induction by alloantigen-induced Treg cell therapy in rat lung transplantation
同种异体抗原诱导的 Treg 细胞疗法在大鼠肺移植中诱导操作耐受
  • 批准号:
    23K08289
  • 财政年份:
    2023
  • 资助金额:
    $ 19.69万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Selective induction of alloantigen-specific humoral tolerance by MHC-Fc fusion proteins
MHC-Fc 融合蛋白选择性诱导同种异体抗原特异性体液耐受
  • 批准号:
    10432434
  • 财政年份:
    2022
  • 资助金额:
    $ 19.69万
  • 项目类别:
Requirements and mechanisms of alloantigen-induced cardiac allograft survival by cDC1s
cDC1同种异体抗原诱导心脏同种异体移植物存活的要求和机制
  • 批准号:
    10744193
  • 财政年份:
    2022
  • 资助金额:
    $ 19.69万
  • 项目类别:
Requirements and mechanisms of alloantigen-induced cardiac allograft survival by cDC1s
cDC1同种异体抗原诱导心脏同种异体移植物存活的要求和机制
  • 批准号:
    10534556
  • 财政年份:
    2022
  • 资助金额:
    $ 19.69万
  • 项目类别:
Selective induction of alloantigen-specific humoral tolerance by MHC-Fc fusion proteins
MHC-Fc 融合蛋白选择性诱导同种异体抗原特异性体液耐受
  • 批准号:
    10612453
  • 财政年份:
    2022
  • 资助金额:
    $ 19.69万
  • 项目类别:
Preventing GVHD by inhibition of alloantigen presentation in the gut
通过抑制肠道内同种抗原的呈现来预防 GVHD
  • 批准号:
    10204102
  • 财政年份:
    2019
  • 资助金额:
    $ 19.69万
  • 项目类别:
Preventing GVHD by inhibition of alloantigen presentation in the gut
通过抑制肠道内同种抗原的呈现来预防 GVHD
  • 批准号:
    10443701
  • 财政年份:
    2019
  • 资助金额:
    $ 19.69万
  • 项目类别:
Preventing GVHD by inhibition of alloantigen presentation in the gut
通过抑制肠道内同种抗原的呈现来预防 GVHD
  • 批准号:
    10737340
  • 财政年份:
    2019
  • 资助金额:
    $ 19.69万
  • 项目类别:
Preventing GVHD by inhibition of alloantigen presentation in the gut
通过抑制肠道内同种抗原的呈现来预防 GVHD
  • 批准号:
    10652374
  • 财政年份:
    2019
  • 资助金额:
    $ 19.69万
  • 项目类别:
Generation of alloantigen-specific Designer Platelets for diagnostic and investigative use
生成用于诊断和研究用途的同种异体抗原特异性设计血小板
  • 批准号:
    9005358
  • 财政年份:
    2016
  • 资助金额:
    $ 19.69万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了